VC: Advisory board: Alcon, Roche, Bayer, Novartis; Grants: Bayer, Novartis. GSS: Nothing to disclose. MRP: Nothing to disclose. DP: Nothing to disclose. JX: Nothing to disclose. DZ: Nothing to disclose. MF: Nothing to disclose. LT: Nothing to disclose. AL: Consultant: Allergan, Bayer, BeyeOnics, ForSight Labs, NotalVision, Novartis, Roche. FGH: Research funds: Acucela, Allergan, Apellis, Bayer, Bioeq/Formycon, Roche/Genentech, Geuder, Heidelberg Engineering, IvericBio, Kanghong, Novartis, NightStarX, Zeiss; Personal fees: Boehringer-Ingelheim, Grayburg Vision, LinBioscience, Pixium Vision, Stealth BioTherapeutics, Aerie, Oxurion. SJG: Consultant: Allergan, Apellis, Bausch and Lomb, Boehringer Ingelheim, Johnson and Johnson, Kanaph; Research funds: American Academy of Ophthalmology, Apellis, Boehringer Ingelheim, NGM Bio, Regeneron. RHG: Advisory boards: Bayer, Novartis, Apellis, Roche, Genentech Inc. PKK: Consultant: Novartis, Bayer, Biogen, Regeneron, Kanghong, Allergan, RegenxBio. MB: Research funds: Pendopharm, Bioventus, Acumed. SF-B: Consultant: Allergan, Bayer, Novartis. SS: Research funds: Novartis, Bayer, Allergan, Roche, Boehringer, Ingelheim and Optos Plc; Travel grants: Novartis, Bayer; Speaker fees: Novartis, Bayer and Optos Plc.; Advisory board: Novartis, Bayer, Allergan, Roche, Boehringer, Ingelheim, Optos Plz, Oxurion, Ophthea, Apellis, Oculis, Heidelberg Engineering. CCW: Consultant: Acuela, Adverum Biotechnologies, Inc, Aerpio, Alimera Sciences, Allegro Ophthalmics, LLC, Allergan, Apellis Pharmaceuticals, Bayer AG, Chengdu Kanghong Pharmaceuticals Group Co, Ltd, Clearside Biomedical, DORC (Dutch Ophthalmic Research Centre), EyePoint Pharmaceuticals, Gentech/Roche, GyroscopeTx, IVERIC bio, Kodiak Sciences Inc, Novartis AG, ONL Therapeutics, Oxurion NV, PolyPhotonix, Recens Medical, Regeron Pharmaceuticals, Inc, REGENXBIO Inc, Santen Pharmaceutical Co, Ltd, and Takeda Pharmaceutical Company Limited; Research funds: Adverum Biotechnologies, Inc, Aerie Pharmaceuticals, Inc, Aerpio, Alimera Sciences, Allergan, Apellis Pharmaceuticals, Chengdu Kanghong Pharmaceutical Group Co, Ltd, Clearside Biomedical, Gemini Therapeutics, Genentech/Roche, Graybug Vision, Inc, GyroscopeTx, Ionis Pharmaceuticals, IVERIC bio, Kodiak Sciences Inc, Neurotech LLC, Novartis AG, Opthea, Outlook Therapeutics, Inc, Recens Medical, Regeneron Pharmaceuticals, Inc, REGENXBIO Inc, Samsung Pharm Co, Ltd, Santen Pharmaceutical Co, Ltd, Xbrane Biopharma AB. No other acknowledgements to list.